Bridgefront Capital, LLC Zimmer Biomet Holdings, Inc. Transaction History

Bridgefront Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$106.25 - $130.01 $442,106 - $540,971	4,161 New	4,161 $451,000
Q4 2022 Feb 14, 2023	SELL	$104.7 - $128.4 $327,501 - $401,635	-3,128 Reduced 62.96%	1,840 $234,000
Q3 2022 Nov 29, 2022	BUY	$101.65 - $119.27 $504,997 - $592,533	4,968 New	4,968 $519,000
Q1 2022 May 13, 2022	SELL	$108.42 - $129.58 $455,797 - $544,754	-4,204 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$115.43 - $146.63 $485,267 - $616,432	4,204 New	4,204 $534,000
Q1 2021 May 17, 2021	SELL	$148.16 - $159.71 $615,901 - $663,914	-4,157 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$128.25 - $151.41 $533,135 - $629,411	4,157 New	4,157 $641,000

1,080

179M

301K

Ticker ZBH
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 209,820,000
Market Cap $23.1B
Description
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.